![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (S)-nicotine | decreases expression | ISO | RGD:1343148 | 6480464 | Nicotine results in decreased expression of CKMT2 mRNA | CTD | PMID:16949557 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:737608 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of CKMT2 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | RGD:737608 | 6480464 | Estradiol results in decreased expression of CKMT2 mRNA | CTD | PMID:19484750 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:737608 | 6480464 | [Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of CKMT2 mRNA | CTD | PMID:15251184 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1343148 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CKMT2 mRNA | CTD | PMID:21296121 | 3-guanidinopropanoic acid | increases expression | EXP | | 6480464 | guanidinopropionic acid results in increased expression of CKMT2 protein | CTD | PMID:9309701 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1343148 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CKMT2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CKMT2 mRNA | CTD | PMID:28628672 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:737608 | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of CKMT2 mRNA | CTD | PMID:18648102 | 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737608 | 6480464 | Decitabine results in increased expression of CKMT2 mRNA | CTD | PMID:15251184 | 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737608 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Decitabine] results in increased expression of CKMT2 mRNA | CTD | PMID:15251184 | 8-Br-cAMP | decreases expression | ISO | RGD:1343148 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CKMT2 mRNA | CTD | PMID:22079614 | acrolein | affects metabolic processing | ISO | RGD:737608 | 6480464 | Acrolein affects the metabolism of CKMT2 protein | CTD | PMID:17921335 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of CKMT2 mRNA | CTD | PMID:28959563 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CKMT2 mRNA | CTD | PMID:16483693 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of CKMT2 mRNA | CTD | PMID:30779732 | arsenite(3-) | increases methylation | ISO | RGD:1343148 | 6480464 | arsenite results in increased methylation of CKMT2 promoter | CTD | PMID:23974009 | benzo[a]pyrene | increases expression | ISO | RGD:1343148 | 6480464 | Benzo(a)pyrene results in increased expression of CKMT2 mRNA | CTD | PMID:22316170 | benzo[a]pyrene | decreases expression | ISO | RGD:737608 | 6480464 | Benzo(a)pyrene results in decreased expression of CKMT2 mRNA | CTD | PMID:22228805 | bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:737608 | 6480464 | Diethylhexyl Phthalate results in increased expression of CKMT2 mRNA | CTD | PMID:28085963 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CKMT2 mRNA | CTD | PMID:25181051, PMID:27178563 | bisphenol A | decreases methylation | ISO | RGD:1343148 | 6480464 | bisphenol A results in decreased methylation of CKMT2 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | RGD:1343148 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CKMT2 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CKMT2 mRNA | CTD | PMID:28628672, PMID:31601247 | bisphenol A | increases expression | ISO | RGD:1343148 | 6480464 | bisphenol A results in increased expression of CKMT2 mRNA, bisphenol A results in increased expression of CKMT2 protein | CTD | PMID:27685785, PMID:34186270 | bisphenol F | multiple interactions | ISO | RGD:1343148 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CKMT2 mRNA | CTD | PMID:28628672 | bisphenol F | increases expression | ISO | RGD:1343148 | 6480464 | bisphenol F results in increased expression of CKMT2 protein | CTD | PMID:34186270 | cadmium atom | multiple interactions | ISO | RGD:1343148 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CKMT2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:1343148 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CKMT2 mRNA | CTD | PMID:35301059 | carbon nanotube | decreases expression | ISO | RGD:737608 | 6480464 | Nanotubes, Carbon analog results in decreased expression of CKMT2 mRNA | CTD | PMID:25620056 | carbon nanotube | increases expression | ISO | RGD:737608 | 6480464 | Nanotubes, Carbon results in increased expression of CKMT2 mRNA | CTD | PMID:25620056 | CGP 52608 | multiple interactions | ISO | RGD:1343148 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CKMT2 gene] | CTD | PMID:28238834 | ciguatoxin CTX1B | affects expression | ISO | RGD:737608 | 6480464 | Ciguatoxins affects the expression of CKMT2 mRNA | CTD | PMID:18353800 | copper(II) chloride | decreases expression | ISO | RGD:737608 | 6480464 | cupric chloride results in decreased expression of CKMT2 protein | CTD | PMID:29617964 | cyclosporin A | increases expression | ISO | RGD:1343148 | 6480464 | Cyclosporine results in increased expression of CKMT2 mRNA | CTD | PMID:25562108 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of CKMT2 mRNA | CTD | PMID:23914054 | dexamethasone | decreases expression | ISO | RGD:737608 | 6480464 | Dexamethasone results in decreased expression of CKMT2 protein | CTD | PMID:33567340 | dexamethasone | multiple interactions | ISO | RGD:1343148 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CKMT2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CKMT2 mRNA | CTD | PMID:28628672 | dichloroacetic acid | decreases expression | ISO | RGD:737608 | 6480464 | Dichloroacetic Acid results in decreased expression of CKMT2 mRNA | CTD | PMID:28962523 | dioxygen | multiple interactions | ISO | RGD:737608 | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CKMT2 mRNA | CTD | PMID:30529165 | doxorubicin | affects localization | EXP | | 6480464 | Doxorubicin affects the localization of CKMT2 protein | CTD | PMID:17935690 | doxorubicin | decreases expression | ISO | RGD:1343148 | 6480464 | Doxorubicin results in decreased expression of CKMT2 mRNA | CTD | PMID:29803840 | doxorubicin | affects expression | ISO | RGD:1343148 | 6480464 | Doxorubicin affects the expression of CKMT2 protein | CTD | PMID:29385562 | doxorubicin | decreases stability | EXP | | 6480464 | Doxorubicin results in decreased stability of CKMT2 protein | CTD | PMID:15764680 | Echimidine | decreases expression | EXP | | 6480464 | echimidine results in decreased expression of CKMT2 mRNA | CTD | PMID:34185104 | fonofos | increases methylation | ISO | RGD:1343148 | 6480464 | Fonofos results in increased methylation of CKMT2 promoter | CTD | PMID:22847954 | fulvestrant | multiple interactions | ISO | RGD:1343148 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CKMT2 gene | CTD | PMID:31601247 | fulvestrant | increases methylation | ISO | RGD:1343148 | 6480464 | Fulvestrant results in increased methylation of CKMT2 gene | CTD | PMID:31601247 | graphite | increases expression | ISO | RGD:737608 | 6480464 | Graphite results in increased expression of CKMT2 mRNA | CTD | PMID:27440207 | Heliotrine | decreases expression | EXP | | 6480464 | heliotrine results in decreased expression of CKMT2 mRNA | CTD | PMID:34185104 | Indeno[1,2,3-cd]pyrene | decreases expression | ISO | RGD:737608 | 6480464 | indeno(1 more ... | CTD | PMID:26377693 | indometacin | multiple interactions | ISO | RGD:1343148 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CKMT2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CKMT2 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | RGD:1343148 | 6480464 | Ivermectin results in decreased expression of CKMT2 protein | CTD | PMID:32959892 | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | decreases expression | ISO | RGD:737608 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CKMT2 mRNA | CTD | PMID:25566086 | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | RGD:737608 | 6480464 | MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CKMT2 mRNA] | CTD | PMID:25566086 | nickel atom | decreases expression | ISO | RGD:1343148 | 6480464 | Nickel results in decreased expression of CKMT2 mRNA | CTD | PMID:24768652, PMID:25583101 | nicotine | decreases expression | ISO | RGD:1343148 | 6480464 | Nicotine results in decreased expression of CKMT2 mRNA | CTD | PMID:16949557 | ozone | decreases expression | ISO | RGD:737608 | 6480464 | Ozone results in decreased expression of CKMT2 mRNA | CTD | PMID:12763052 | ozone | increases phosphorylation | EXP | | 6480464 | Ozone results in increased phosphorylation of CKMT2 protein | CTD | PMID:33146391 | paracetamol | decreases expression | ISO | RGD:1343148 | 6480464 | Acetaminophen results in decreased expression of CKMT2 mRNA | CTD | PMID:25704631 | parathion | increases methylation | ISO | RGD:1343148 | 6480464 | Parathion results in increased methylation of CKMT2 promoter | CTD | PMID:22847954 | pioglitazone | multiple interactions | ISO | RGD:737608 | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CKMT2 mRNA | CTD | PMID:27935865 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CKMT2 mRNA | CTD | PMID:12832660 | Platyphylline | decreases expression | EXP | | 6480464 | platyphylline results in decreased expression of CKMT2 mRNA | CTD | PMID:34185104 | resveratrol | multiple interactions | ISO | RGD:1343148 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of CKMT2 mRNA | CTD | PMID:23557933 | senecionine | decreases expression | EXP | | 6480464 | senecionine results in decreased expression of CKMT2 mRNA | CTD | PMID:34185104 | streptozocin | multiple interactions | EXP | | 6480464 | vanadyl sulfate inhibits the reaction [Streptozocin results in decreased expression of CKMT2 mRNA] | CTD | PMID:16684804 | streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of CKMT2 mRNA | CTD | PMID:16684804 | sunitinib | decreases expression | ISO | RGD:1343148 | 6480464 | Sunitinib results in decreased expression of CKMT2 mRNA | CTD | PMID:31533062 | T-2 toxin | decreases expression | EXP | | 6480464 | T-2 Toxin results in decreased expression of CKMT2 mRNA | CTD | PMID:26141394 | terbufos | increases methylation | ISO | RGD:1343148 | 6480464 | terbufos results in increased methylation of CKMT2 promoter | CTD | PMID:22847954 | titanium dioxide | decreases expression | ISO | RGD:737608 | 6480464 | titanium dioxide results in decreased expression of CKMT2 mRNA | CTD | PMID:23557971 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of CKMT2 gene | CTD | PMID:27618143 | tunicamycin | increases expression | ISO | RGD:737608 | 6480464 | Tunicamycin results in increased expression of CKMT2 mRNA | CTD | PMID:17127020 | vanadyl sulfate | multiple interactions | EXP | | 6480464 | vanadyl sulfate inhibits the reaction [Streptozocin results in decreased expression of CKMT2 mRNA] | CTD | PMID:16684804 | XL147 | multiple interactions | ISO | RGD:737608 | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CKMT2 mRNA | CTD | PMID:27935865 | |